Q3 2023 · 13F-HR
Logos Global Management LPholdings as filed
Filed 2023-11-14 · accession 0001172661-23-003853
$749.5M
Reported value
56
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 45258J102 | IMVT | IMMUNOVANT INC | $61.4M | 8.19% | 1,600,000 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $60.7M | 8.10% | 2,250,000 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $46.2M | 6.17% | 3,743,875 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $40.5M | 5.40% | 1,975,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $36.8M | 4.91% | 1,250,000 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $30.3M | 4.05% | 600,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $28.5M | 3.81% | 750,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $25.2M | 3.36% | 500,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $24.7M | 3.30% | 650,000 | CALL | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $24.2M | 3.23% | 200,000 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $23.4M | 3.12% | 450,000 | Common | SOLE |
| 45114M109 | — | ICOSAVAX INC | $21.4M | 2.86% | 2,765,741 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $19.5M | 2.61% | 2,180,000 | Common | SOLE |
| 48576A100 | — | KARUNA THERAPEUTICS INC | $19.4M | 2.59% | 115,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $16.9M | 2.25% | 150,000 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $16.1M | 2.15% | 1,050,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $15.4M | 2.05% | 450,000 | Common | SOLE |
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $15.3M | 2.04% | 700,000 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $14.0M | 1.87% | 1,200,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $13.2M | 1.76% | 500,000 | CALL | SOLE |
| 60468T105 | MRTXEUR | MIRATI THERAPEUTICS INC | $13.1M | 1.74% | 300,000 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $12.5M | 1.67% | 5,300,000 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $12.2M | 1.62% | 1,050,000 | Common | SOLE |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $11.9M | 1.58% | 5,032,501 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $10.6M | 1.41% | 4,650,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $10.5M | 1.41% | 400,000 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $9.2M | 1.22% | 400,000 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $8.7M | 1.16% | 900,000 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $7.8M | 1.04% | 225,000 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $7.4M | 0.99% | 250,000 | Common | SOLE |
| 38406L103 | — | GRACELL BIOTECHNOLOGIES INC | $7.3M | 0.97% | 2,525,000 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $7.0M | 0.94% | 950,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $6.9M | 0.92% | 250,000 | Common | SOLE |
| 617760202 | MOR2 | MORPHOSYS AG | $6.4M | 0.85% | 950,000 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $6.0M | 0.81% | 500,000 | CALL | SOLE |
| 374163103 | GERN | GERON CORP | $5.8M | 0.78% | 2,750,000 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $5.8M | 0.77% | 245,000 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $4.8M | 0.64% | 1,000,000 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $4.8M | 0.64% | 310,000 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $4.5M | 0.61% | 1,000,000 | CALL | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $4.2M | 0.56% | 1,044,444 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $4.2M | 0.56% | 307,076 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $4.1M | 0.54% | 544,960 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $3.7M | 0.49% | 125,000 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $3.6M | 0.48% | 300,000 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $2.9M | 0.38% | 215,000 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $2.8M | 0.37% | 424,000 | Common | SOLE |
| 00773J202 | SYRE | AEGLEA BIOTHERAPEUTICS INC | $2.6M | 0.34% | 210,000 | Common | SOLE |
| 02290A102 | — | AMBRX BIOPHARMA INC | $1.3M | 0.18% | 115,000 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $1.0M | 0.14% | 188,390 | Common | SOLE |
| 449778109 | IOBTQ | IO BIOTECH INC | $696,296 | 0.09% | 493,827 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $619,140 | 0.08% | 421,184 | Common | SOLE |
| 52187K200 | CYPH | LEAP THERAPEUTICS INC | $488,887 | 0.07% | 354,266 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $438,877 | 0.06% | 31,872 | Common | SOLE |
| 53000N108 | LIANY | LIANBIO | $417,200 | 0.06% | 280,000 | Common | SOLE |
| 67080N119 | NUVB/WS | NUVATION BIO INC | $6,667 | 0.00% | 66,666 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.